These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2140740)

  • 1. [Patients with stroke treated with TRH-T. Evaluation of electric brain activity using traditional and computerized methods].
    Bramanti P; Di Bella P; Ricci RM; De Luca GP; De Bartolo M; Di Perri R
    Clin Ter; 1990 Apr; 133(1):19-23. PubMed ID: 2140740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiological findings after TRH-T administration to healthy volunteers].
    Bramanti P; Di Bella P; Ricci RM; De Luca GP; De Leo M; Di Perri R
    Clin Ter; 1990 Mar; 132(6):405-8. PubMed ID: 2139386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protirelin in the treatment of cerebrovascular disorders].
    Costa R; Cirrincione M; Chinnici M; Scaffidi A
    Clin Ter; 1990 Aug 15-31; 134(3-4):205-9. PubMed ID: 2147622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of protirelin tartrate (TRH-T) in the rehabilitation of the post-stroke patient. XC National Congress of the Italian Society of Internal Medicine. Rome, 16-20 October 1990].
    Ann Ital Med Int; 1990; 5(3 Pt 2):229-80. PubMed ID: 1981835
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neuropsychologic and clinical effects of protirelin tartrate in patients with stroke sequelae].
    Fioravanti M
    Ann Ital Med Int; 1990; 5(3 Pt 2):254-61. PubMed ID: 2127687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of TRH-T for the symptomatic treatment of the pathology of the upper motoneurons and electrophysiologic evaluation of its efficacy].
    Martinelli P
    Ann Ital Med Int; 1990; 5(3 Pt 2):262-9. PubMed ID: 2127688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in blood levels of the pituitary-thyroid axis observed during therapy with protirelin ++ in hospitalized euthyroid patients with cerebrovascular disease].
    Custro N; Scafidi V; Costanzo G; Corsello FP
    Minerva Med; 1991; 82(7-8):453-7. PubMed ID: 1922889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficacy and tolerability of protirelin. Results of a multicenter study in Italy].
    Eandi M; Signorile F; Rubinetto MP; Genazzani E
    Ann Ital Med Int; 1990; 5(3 Pt 2):270-8. PubMed ID: 2127689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tolerance of long-term protirelin tartrate treatment].
    Caraccio N; Monzani F; Casolaro A; Pucci E; Luisi M; Franchi F
    Recenti Prog Med; 1995 Jun; 86(6):226-30. PubMed ID: 7624581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of thyrotropin-releasing hormone tartrate (TRH-T) as a direct stimulant to the central nervous system.
    Ogashiwa M; Takeuchi K
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):145-51. PubMed ID: 36357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of thyrotropin-releasing horomone tartrate (TRH-T) as a direct stimulant to the central nervous system (author's transl)].
    Ogashiwa M; Takeuchi K
    Rinsho Shinkeigaku; 1977 Oct; 17(10):655-64. PubMed ID: 413683
    [No Abstract]   [Full Text] [Related]  

  • 12. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood.
    Yoshinari S; Hamano S; Tanaka M; Minamitani M
    Eur J Paediatr Neurol; 2006 May; 10(3):124-8. PubMed ID: 16757195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI; Hallenbeck JM; Brown CQ
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alteration of CBF and CMRO2 and TRH effects on CBF in spinocerebellar degeneration. The positron emission tomography study].
    Harada K; Fukuyama H; Miyoshi T; Namura Y; Kameyama M
    Rinsho Shinkeigaku; 1988 May; 28(5):563-8. PubMed ID: 3145826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of various hormones in successive administration of TRH-tartrate (TRH-T) (author's transl)].
    Miyoshi M; Takahara J; Miura H; Yamauchi J; Nakajima Y
    Horumon To Rinsho; 1979 Sep; 27(9):1055-62. PubMed ID: 118831
    [No Abstract]   [Full Text] [Related]  

  • 17. TRH treatment in psychiatric patients--effects on the pituitary-thyroid axis and on the EEG sleep pattern.
    Cassano GB; Castrogiovanni P; Maggini C
    Psychopharmacol Bull; 1975 Oct; 11(4):66-7. PubMed ID: 812137
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and CNS effects of oral and I.V. Thyrotropin-releasing hormone in depressed patients.
    Itil TM; Patterson CD; Polvan N; Bigelow A; Bergey B
    Dis Nerv Syst; 1975 Sep; 36(9):529-36. PubMed ID: 809253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of thyroliberin on the central nervous system].
    Aslanov AS; Lavretskaia GI
    Probl Endokrinol (Mosk); 1987; 33(4):51-5. PubMed ID: 3116536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thyrotropin-releasing hormone (TRH) on motor performance of hemiparetic stroke patients.
    Nakamura R; Fujita M
    Tohoku J Exp Med; 1990 Feb; 160(2):141-3. PubMed ID: 2112792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.